CC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Chemours Co is not a compelling buy at this moment for a beginner investor with a long-term strategy. The stock lacks strong positive catalysts, the technical indicators are neutral to bearish, and the financial performance shows mixed signals with declining revenue and gross margin. While analysts have slightly increased price targets, the sentiment remains largely neutral. The options data also suggests a lack of strong bullish sentiment. For a long-term investor, it may be better to wait for clearer positive signals or improved financial performance before considering an entry.
The MACD histogram is negative and expanding, indicating bearish momentum. RSI is at 37.059, which is in the neutral zone but trending towards oversold territory. Moving averages are converging, showing no clear trend. Key support is at 16.439, and the stock is trading close to this level, suggesting potential downside risk.
The sale of the Taiwan TiO2 site for $360M provides liquidity for debt reduction and future growth opportunities.
The Q1 guidance for breakeven profitability in key segments is challenging. Technical indicators are bearish, and the stock is trading near support levels. No recent news or significant insider/hedge fund activity to drive positive sentiment.
In Q4 2025, revenue dropped by -2.13% YoY to $1.33 billion. Net income improved to -$61 million, up 408.33% YoY, but remains negative. EPS increased to -0.41, up 412.50% YoY. Gross margin dropped significantly to 11.95%, down -39.19% YoY, indicating declining profitability.
Analysts have slightly increased price targets, with the highest being $23 (UBS) and the lowest being $17 (multiple firms). Ratings are mixed, with Neutral, Equal Weight, and Outperform ratings dominating. Analysts highlight challenges in profitability and headwinds in key segments but acknowledge some positive developments like the Taiwan TiO2 site sale.
